NVAX
USDNovavax Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$7.685
Kõrge
$7.860
Madal
$7.500
Maht
5.04M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
1.2B
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
6.00M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
TD Cowen Maintains Hold on Novavax, Lowers Price Target to $7
TD Cowen analyst Brendan Smith maintains Novavax with a Hold and lowers the price target from $8 to $7.
Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment
Novavax, Inc. (Nasdaq: NVAX) has completed the transfer of the U.S. marketing authorization for its COVID-19 vaccine, Nuvaxovid™ to Sanofi, enabling...
Cantor Fitzgerald Initiates Coverage On Novavax with Overweight Rating, Announces Price Target of $18
Cantor Fitzgerald analyst Pete Stavropoulos initiates coverage on Novavax with a Overweight rating and announces Price Target of $18.
HC Wainwright & Co. Maintains Buy on Novavax, Raises Price Target to $11
HC Wainwright & Co. analyst Sean Lee maintains Novavax with a Buy and raises the price target from $10 to $11.
Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy
Novavax, Inc. (Nasdaq: NVAX) today announced that it has further executed against its planned transformation into a lean, agile operating model by...
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.